Skip to main content
PLOS One logoLink to PLOS One
. 2020 Sep 23;15(9):e0238395. doi: 10.1371/journal.pone.0238395

Evaluation of biomechanically corrected intraocular pressure using Corvis ST and comparison of the Corvis ST, noncontact tonometer, and Goldmann applanation tonometer in patients with glaucoma

Yoshitaka Nakao 1,*, Yoshiaki Kiuchi 1, Hideaki Okumichi 1
Editor: Rajiv R Mohan2
PMCID: PMC7510959  PMID: 32966284

Abstract

Purpose

The aim of the study was to investigate the effects of various anatomical structures on intraocular pressure (IOP) measurements obtained by the Corneal Visualization Scheimpflug Technology (Corvis ST), Goldmann applanation tonometer (GAT), and noncontact tonometer (NCT), as well as to assess the interchangeability among the four types of IOP measurement: IOP-GAT, IOP-NCT, IOP-Corvis, and biomechanically corrected IOP (bIOP-Corvis), with a particular focus on bIOP-Corvis.

Materials and methods

We included 71 patients with primary open-angle glaucoma and assessed their IOP measurements obtained with the GAT, NCT, and Corvis ST using a repeated measures ANOVA, a paired t-test with Bonferroni correction, stepwise multiple regression analyses and Bland–Altman plots.

Results

IOP-GAT showed the highest values (13.5 ± 2.1 mmHg [mean ± standard deviation]), followed by IOP-NCT (13.2 ± 2.7 mmHg), IOP-Corvis (10.6 ± 2.8 mmHg), and bIOP-Corvis (10.0 ± 2.3 mmHg). With exceptions of bIOP-Corvis and IOP-GAT, all IOP variations were explained by regression coefficients involving the central corneal thickness. Bland–Altman plots showed a mean difference between IOP-GAT and the other IOP measurements (IOP-Corvis, bIOP-Corvis, and IOP-NCT), which were -2.90, -3.48, and -0.29 mmHg, respectively. The widths of the 95% limits of agreement between all pairs of IOP measurements were greater than 3 mmHg.

Conclusion

IOP values obtained with the Corvis ST, NCT, and GAT were not interchangeable. The bIOP-Corvis measurement corrected for the ocular structure.

Introduction

Intraocular pressure (IOP) is the only treatable risk factor in the management of patients with glaucoma. Previous studies have shown that even a mean IOP increase of 1 mmHg may substantially increase the risk for development and progression of glaucoma [1]. Therefore, precise and accurate assessment of IOP is crucial for proper management of patients with glaucoma. An ideal tonometer should be precise, accurate, and minimally influenced by factors, such as ocular biomechanical parameters. The Goldmann applanation tonometer (GAT) is presently the gold standard for clinical IOP measurements, and the traditional noncontact tonometer (NCT) is widely used in optometric practice as it is rapid and simple to operate with respect to measurement of IOP. Nevertheless, IOP readings increased as the CCT increased [212], axial length decreased [13, 14], age increased [9, 12], and the corneal curvature decreased [8, 15] when the two tonometers are used.

In 2005, to provide a corrected IOP unaffected by CCT, the Ocular Response Analyzer (ORA; Reichert, Delpew, NY, USA) was introduced [16]. The ORA was the first non-contact tonometer to convert corneal biomechanics into numerical values using dynamic infrared signal analysis of the corneal biomechanical response. However, the ORA cannot provide a direct description of the mechanical behavior of the cornea.

More recently, the Corneal Visualization Scheimpflug Technology (Corvis ST; Oculus, Wetzlar, Germany) has been introduced as a novel non-contact tonometer designed to accurately measure IOP and the detailed biomechanical response of the cornea to an air pulse. The Corvis ST records the corneal reaction to a defined air pulse with a Scheimpflug imaging system that takes about 4,330 images per second. Then, it estimates the corrected IOP without the influence of ocular biomechanical parameters, including CCT or aging; it is named as IOPpachy-Corvis. Previously, we compared the IOPpachy-Corvis and the IOP obtained with GAT; it is named as IOP-GAT, and found that the two measurements were not interchangeable. This may be because IOPpachy-Corvis was not sufficiently unaffected by the ocular biomechanical parameters [11]. However, in 2016, Corvis ST developed a new parameter called biomechanically corrected IOP (bIOP-Corvis). This new parameter accounts for the dynamic corneal response in addition to the anatomical corneal structures. It is an estimate of the corrected IOP that is minimally influenced by the ocular biomechanical parameters, such as age, CCT, and radius at the highest concavity. The bIOP-Corvis formula [17, 18] is as follows:

bIOP = CCCT1 × CAP1 × Cage1 + CCCT2 × Cage2 + CDCR + a19

where

CCCT1 = (a1 × CCT3 + a2 × CCT2 + a3 × CCT + a4)

CAP1 = (a5 × AP1 + a6)

Cage1 = (a7 × [Ln(Beta)]2 + a8 × [Ln(Beta)] + a9)

CCCT2 = (a10 × CCT3 + a11 × CCT2 + a12 × CCT + a13)

Cage2 = (a14 × [Ln(Beta)]2 + a15 × [Ln(Beta)] + a16)

Beta = 0.5852 × exp(0.0111 × age[year])

CDCR = a17 × highest concavity radius + a18

Thus, the biomechanical parameter correction performed is more precise.

The aim of this study was to investigate the effects of various anatomical structures on the IOP measurements obtained with the GAT, NCT, and Corvis ST as well as to assess the interchangeability among four types of IOP measurements, IOP-GAT, IOP-NCT, IOP-Corvis, and bIOP-Corvis, with a particular focus on bIOP-Corvis.

Materials and methods

This prospective and comparative analysis of IOP values was performed in Hiroshima University Hospital on 71 right eyes of 71 participants with primary open-angle glaucoma (POAG) recruited from September 2014 to March 2015. The institutional board of Hiroshima University Hospital approved the study and waived the need for informed consent owing to the prospective chart review that was created for explanation of the implications of such activities and listed on a poster in the hospital. This study was registered with the University Hospital Medical Network clinical trials registry, and the registration number was JPRN-U-MIN000016623. The authors adhered to the tenets of the Declaration of Helsinki.

The exclusion criteria included intraocular surgery or refractive laser treatment and any systemic or ocular pathology that could affect the IOP measurements; refractive error equal to or exceeding -6.00 diopter equivalent sphere, and corneal astigmatism equal to or exceeding 3.00 diopters; ocular hypertension; diabetes [19]; pregnancy [20]; and Scheimpflug images with a low quality, which cannot be automatically analyzed.

All patients underwent the following examinations on the same day: complete ophthalmologic examination, including spherical equivalent refraction and the average of the horizontal and vertical corneal curvatures (KR-800 ®; Topcon Corporation, Tokyo, Japan, axial length (IOL master ®; Carl Zeiss Meditec AG, Jena, Germany), as well as CCT (Corvis ST). IOP values were obtained with the Corvis ST, CT-90A (Topcon Corporation, Tokyo, Japan) and GAT. Experienced clinicians measured the IOP thrice using each device between 10:00 and 17:00. First, in all cases, the IOP measurements were obtained in a randomized order−CT-90A or Corvis ST−by the same clinicians with a 5-min interval between use of each device. After another 30-min interval, topical anesthesia with 0.4% oxybuprocaine hydrochloride and fluorescein staining was induced, following which, GAT measurements were taken by a masked ophthalmologist.

Statistical analysis

IOP measurements were compared using a repeated measures ANOVA and a paired t-test with Bonferroni correction. A sample size of 50 participants was needed to achieve 80% power to detect a minimal clinically important difference of 1.5 mmHg, assuming a standard deviation of 1.75 mmHg in the differences between IOPs, a significance level of 0.05, and a 10% patient ineligibility. We utilized univariate regression models to study factors (age, corneal curvature, axial length, and CCT) associated with each IOP measurement obtained with three tonometers. Subsequently, all-subsets and stepwise multivariate linear regression analyses were utilized to construct models that best identified the independent factors associated with the IOP measurements. We used the variance inflation factor (VIF) for each term in the mode used for the potential collinearity problem. A VIF was equal to or exceeding 5.0 indicated a collinearity issue among the terms in the multivariate regression analyses. The target sample size estimates were based on the effect size f2 (0.15); number of predictors (4); significance level (0.05); and power (80%). Considering 10% of patients to be ineligible, the target sample size was determined to be at least 61 patients. The 95% limits of agreement (LOAs) between methods (the mean difference ± 1.96 SD contained 95% of the inter-method differences) were evaluated using Bland–Altman plots, which also assessed simultaneous visual examinations for both fixed and proportional biases. P-values less than 0.05 were considered significant.

Results

Demographic data are summarized in Table 1.

Table 1. Demographics and ocular characteristics of patients (POAG, n = 71).

Mean ± SD Range
Visual acuity (logMAR) -0.005 ± 0.21 -1.08–1.00
Age (year) 62.75 ± 11.68 30.8–79.4
Sex (n, female) 31
Axial length (mm) 25.16 ± 1.74 22.1–29.2
Average corneal curvature (mm) 7.73 ± 0.28 7.14–8.45
Central corneal thickness (μm) 536 ± 33.85 460–635

POAG, primary open-angle glaucoma; logMAR, logarithm of the minimum angle of resolution; SD, standard deviation

Corvis ST, NCT, and GAT were used to measure the IOP of the right eyes of 71 participants.

Overall, the IOP-GAT measurements had the highest values (13.5 ± 2.1 mmHg [mean ± SD]), followed by IOP-NCT (13.2 ± 2.7 mmHg), IOP-Corvis (10.6 ± 2.8 mmHg), and bIOP-Corvis (10.0 ± 2.3 mmHg). We found a significant difference between the IOP measurements by using a repeated measures ANOVA (all, p <0.001). In the paired t-test with Bonferroni correction, bIOP-Corvis obtained significantly the lowest values of the four IOP measurements (all, p <0.001). IOP-Corvis produced significantly lower values than IOP-NCT and IOP-GAT (all, p <0.001); however, we found no significant differences between IOP-NCT and IOP-GAT (p >0.05).

Using univariate regression analyses, only CCT was associated with IOP-Corvis and IOP-NCT (Table 2). We used stepwise multivariate regression analyses to adjust for the interactions among variables. CCT independently influenced IOP-Corvis (standardized β = 0.35; p = 0.003) and IOP-NCT (standardized β = 0.42; p = 0.0003). None of these factors influenced bIOP-Corvis or IOP-GAT. The VIFs of identified factors in the stepwise multivariate regression analysis ranged from 1.0 to 1.1.

Table 2. Factors independently associated with IOP measurements in the univariate and multiple regression analyses.

Independent variables IOP measurements
bIOP-Corvis IOP-Corvis IOP-NCT IOP-GAT
Standardized β p VFI Standardized β p VFI Standardized β p VFI Standardized β p VFI
Univariate regression analysis
Age (year) -0.13 0.282 0.00 0.992 -0.161 0.180 0.004 0.976
Average corneal curvature (mm) -0.16 0.177 -0.18 0.142 0.076 0.527 -0.050 0.677
Axial length (mm) 0.05 0.697 0.04 0.748 0.164 0.172 0.030 0.802
Central corneal thickness (μm) 0.01 0.926 0.34 0.004 0.419 0.000 0.179 0.136
Stepwise multivariate regression analysis
Age (year) 1.1
Average corneal curvature (mm) 1.1 -0.19 0.089 1.0
Axial length (mm)
Central corneal thickness (μm) 0.35 0.003 1.0 0.419 0.000

VFI, variance inflation factor; IOP, intraocular pressure; IOP-Corvis indicates IOP by Corvis ST; bIOP-Corvis, corrected IOP-Corvis; IOP-GAT, IOP by Goldmann applanation tonometry; IOP-NCT, the IOP obtained by CT-90A tonometer.

Fig 1 shows the Bland–Altman plots for the agreement between the IOP measurements.

Fig 1. Bland–Altman plots between IOPs obtained with the Corvis ST, GAT, and CT-90A.

Fig 1

A, IOP-Corvis and IOP-GAT. B, bIOP-Corvis and IOP-GAT. C, IOP-NCT and IOP-GAT. The mean values and 95% LOA are indicated by bold lines and solid lines, respectively. IOP, intraocular pressure; IOP-Corvis, the IOP obtained by Corvis ST; bIOP-Corvis, corrected IOP-Corvis; IOP-GAT, the IOP obtained by Goldmann applanation tonometry; IOP-NCT, the IOP obtained by CT-90A tonometer; LOA, limits of agreement.

The mean difference between IOP-Corvis and IOP-GAT was -2.90 mmHg; the 95% LOA was 3.80 mmHg, and a fixed bias was present (p <0.0001), but we detected a weak proportional bias (r2 = 0.15; p = 0.0008) (Fig 1A). The results of a comparison between bIOP-Corvis and IOP-GAT show that mean difference was -3.48 mmHg, and the 95% LOA was the narrowest at 3.42 mmHg. We identified a fixed bias (p <0.0001) but did not detect any proportional bias (r2 = 0.02; p = 0.21) (Fig 1B). In comparison between IOP-NCT and IOP-GAT, the mean difference was -0.29 mmHg, the 95% LOA was 3.72 mmHg, and no fixed bias was present (p = 0.20). However, we identified a weak proportional bias (r2 = 0.14; p = 0.0016) (Fig 1C).

Discussion

This study investigated the effects of various anatomical structures on IOP measurements obtained with three devices as well as the interchangeability among four types of IOP measurements. The findings in this study indicated that no anatomical factors were associated with bIOP-Corvis or IOP-GAT. Furthermore, the comparison between bIOP-Corvis and IOP-GAT resulted in the narrowest 95% LOA (3.42 mmHg) and no proportional bias. A fixed bias of the comparison between bIOP-Corvis and GAT-IOP showed the highest value (-3.48 mmHg); therefore, bIOP-Corvis significantly underestimated IOP-GAT.

Factors affecting the corrected IOP and noncorrected IOP measurements

Many factors can influence the measurement accuracy. Factors that influence IOP measurements are mostly CCT [27, 9, 10, 21], corneal curvature [15], and axial length [13, 14]. In this study, the stepwise multivariate linear regression analyses were used to detect the anatomical and structural factors associated with IOP measurements. CCT was the only significant factor, and it was associated with IOP-Corvis (standardized β = 0.35; p = 0.003) and IOP-NCT (standardized β = 0.42; p = 0.0003) but not with bIOP-Corvis or IOP-GAT (standardized β = 0.179; p = 0.136). The bIOP-Corvis values were calibrated to eliminate the effect of CCT but the IOP-Corvis values were not. Moreover, GAT and NCT are generally affected by CCT, but NCT is more influenced by CCT than GAT [3, 57]. This outcome may be explained by these reasons.

Agreement between the three IOP measurements and IOP-GAT

To date, many studies have assessed the agreement among bIOP-Corvis, IOP-Corvis, IOP-GAT, and IOP-NCT. There was a fixed bias in the comparison between the three IOP readings and the IOP-GAT values. Bland–Altman plots revealed that the fixed bias of the comparison between bIOP-Corvis and IOP-GAT values, IOP-Corvis and IOP-GAT values, and IOP-NCT and IOP-GAT values in the present study were -3.48, -2.90, -0.29 mmHg, respectively. Recently, Vinciguerra R et al. [22] reported the mean differences between bIOP-Corvis and IOP-GAT. In healthy control eyes and eyes with ocular hypertension, POAG, and normal-tension glaucoma, IOP-GAT were 16.4 ± 2.4, 22.1 ± 4.8, 17.2 ± 4.9, and 13.7 ± 1.8, respectively, and bIOP-Corvis were 13.4 ± 2.8, 17.0 ± 4.1, 14.8 ± 3.1, and 12.9 ± 2.3, respectively. In other words, the bIOP-Corvis values were smaller than the GAT-IOP values in all groups. In a previous study, the fixed bias [10, 21, 2325] of the comparison between IOP-Corvis and IOP-GAT and the fixed bias [23, 2628] of the comparison between IOP-NCT and IOP-GAT were smaller than the fixed bias of the comparison between bIOP-Corvis and IOP-GAT.

In our study, no proportional bias was present for comparisons between bIOP-Corvis and IOP-GAT; however, a proportional bias was present for comparisons between IOP-Corvis and IOP-GAT and between IOP-NCT and IOP-GAT. In a previous study, the proportional bias was identically present for IOP-Corvis and IOP-GAT [10, 21]. This showed that the differences between two IOP values (bIOP-Corvis and IOP-GAT) neither increase nor decrease in proportion to the average values; therefore, it can be easily converted from bIOP-Corvis to IOP-GAT.

In our study, the relationships between the 95% LOAs were as follows: The bIOP-Corvis and IOP-GAT had the lowest of the three 95% LOA widths of 3.42 mmHg, and the 95% LOAs between IOP-Corvis and IOP-GAT and between IOP-NCT and IOP-GAT were 3.80 and 3.72 mmHg, respectively. Most recently, Ye Y et al. showed that the 95% LOAs between bIOP-Corvis and IOP-GAT was 3.84 mmHg [12]. In many studies, the 95% LOAs between IOP-Corvis and IOP-GAT ranged widely: +4.40 [24], +4.80 [23], +5.40 [10], +6.05 [21], and +8.00 [25] mmHg. In some studies, the 95% LOAs between IOP-NCT and IOP-GAT also had a wide range: +2.17 [26], +3.30 [27], +4.60 [28], and +7.20 [23] mmHg, which means that bIOP-Corvis steadily measures IOP readings accurately when compared to the non-corrected IOP measurements in IOP-Corvis and IOP-NCT.

Advantages and disadvantages of bIOP-Corvis

Most commercially available tonometers estimate IOP based on the corneal applanation or indentation. Therefore, measured values of IOP are generally influenced by corneal biomechanics. The bIOP-Corvis is an estimate of the corrected IOP, which is minimally influenced by ocular biomechanical parameters. In this study, we used regression analyses to investigate the anatomical and structural factors that affect the bIOP-Corvis measurements. We found that age, average corneal curvature, axial length, and CCT were not significant factors that influence bIOP-Corvis. However, our result of the Bland–Altman plots for bIOP-Corvis and IOP-GAT showed that fixed biases were identified. This means that bIOP-Corvis significantly underestimated IOP using the standard clinical tonometer for measurements. Nevertheless, proportional bias was not between the bIOP-Corvis and IOP-GAT measurements and the 95% LOAs was relatively low. Therefore, it seems that we can convert from bIOP-Corvis to IOP-GAT. Our result implied that the bIOP-Corvis is a useful IOP value in patients with POAG.

Our study has several limitations. First, it is still not clear which IOP measurement is closest to the true value. We evaluated the Corvis ST and CT-90A in comparison with GAT; however, the IOP-GAT is not a true IOP value. Second, our participants included only patients with POAG. It is unclear whether our results can be applicable to healthy patients and those without POAG. Third, our participants were treated using antiglaucoma medications, which are intended to reduce elevated intraocular pressure. Thus, the IOPs measured in our participants all seemed within the normal range. Our results may not generalize to those with higher IOP measurements. Fourth, our study did not consider other factors that may influence IOP readings, such as visual acuity [29, 30] and number of antiglaucoma medications [31, 32], and future research is desired in this aspect.

In conclusion, we showed that no anatomical factors were associated with bIOP-Corvis. The comparison between bIOP-Corvis and IOP-GAT resulted in the narrowest 95% LOA with no proportional bias. We can convert bIOP-Corvis to IOP-GAT by correcting the fixed biases. The Corvis ST devices offer new possibilities for clinically useful tonometers.

Acknowledgments

We would like to thank Editage (www.editage.com) for English language editing.

Data Availability

All our study datas are available from the figshare database (10.6084/m9.figshare.11954748).

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–79. Epub 2002/10/09. 10.1001/archopht.120.10.1268 . [DOI] [PubMed] [Google Scholar]
  • 2.Ehlers N, Bramsen T, Sperling S. Applanation tonometry and central corneal thickness. Acta Ophthalmol (Copenh). 1975;53(1):34–43. Epub 1975/03/01. 10.1111/j.1755-3768.1975.tb01135.x . [DOI] [PubMed] [Google Scholar]
  • 3.Graf M. [Significance of the corneal thickness in non-contact tonometry]. Klin Monbl Augenheilkd. 1991;199(3):183–6. Epub 1991/09/01. 10.1055/s-2008-1046068 . [DOI] [PubMed] [Google Scholar]
  • 4.Whitacre MM, Stein RA, Hassanein K. The effect of corneal thickness on applanation tonometry. Am J Ophthalmol. 1993;115(5):592–6. Epub 1993/05/15. 10.1016/s0002-9394(14)71455-2 . [DOI] [PubMed] [Google Scholar]
  • 5.Matsumoto T, Makino H, Uozato H, Saishin M, Miyamoto S. The influence of corneal thickness and curvature on the difference between intraocular pressure measurements obtained with a non-contact tonometer and those with a Goldmann applanation tonometer. Jpn J Ophthalmol. 2000;44(6):691 Epub 2000/11/30. 10.1016/s0021-5155(00)00250-1 . [DOI] [PubMed] [Google Scholar]
  • 6.Recep OF, Hasiripi H, Cagil N, Sarikatipoglu H. Relation between corneal thickness and intraocular pressure measurement by noncontact and applanation tonometry. J Cataract Refract Surg. 2001;27(11):1787–91. Epub 2001/11/16. 10.1016/s0886-3350(01)00900-2 . [DOI] [PubMed] [Google Scholar]
  • 7.Tonnu PA, Ho T, Newson T, El Sheikh A, Sharma K, White E, et al. The influence of central corneal thickness and age on intraocular pressure measured by pneumotonometry, non-contact tonometry, the Tono-Pen XL, and Goldmann applanation tonometry. Br J Ophthalmol. 2005;89(7):851–4. Epub 2005/06/21. 10.1136/bjo.2004.056622 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Medeiros FA, Weinreb RN. Evaluation of the influence of corneal biomechanical properties on intraocular pressure measurements using the ocular response analyzer. J Glaucoma. 2006;15(5):364–70. Epub 2006/09/22. 10.1097/01.ijg.0000212268.42606.97 . [DOI] [PubMed] [Google Scholar]
  • 9.Garcia-Medina M, Garcia-Medina JJ, Garrido-Fernandez P, Galvan-Espinosa J, Martin-Molina J, Garcia-Maturana C, et al. Central corneal thickness, intraocular pressure, and degree of myopia in an adult myopic population aged 20 to 40 years in southeast Spain: determination and relationships. Clin Ophthalmol. 2011;5:249–58. Epub 2011/04/07. 10.2147/OPTH.S16594 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Salvetat ML, Zeppieri M, Tosoni C, Felletti M, Grasso L, Brusini P. Corneal Deformation Parameters Provided by the Corvis-ST Pachy-Tonometer in Healthy Subjects and Glaucoma Patients. J Glaucoma. 2015;24(8):568–74. Epub 2014/10/17. 10.1097/IJG.0000000000000133 . [DOI] [PubMed] [Google Scholar]
  • 11.Nakao Y, Kiuchi Y, Okimoto S. A Comparison of the Corrected Intraocular Pressure Obtained by the Corvis ST and Reichert 7CR Tonometers in Glaucoma Patients. PloS one. 2017;12(1):e0170206 Epub 2017/01/18. 10.1371/journal.pone.0170206 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Ye Y, Yang Y, Fan Y, Lan M, Yu K, Yu M. Comparison of Biomechanically Corrected Intraocular Pressure Obtained by Corvis ST and Goldmann Applanation Tonometry in Patients With Open-angle Glaucoma and Ocular Hypertension. J Glaucoma. 2019;28(10):922–8. Epub 2019/08/28. 10.1097/IJG.0000000000001348 . [DOI] [PubMed] [Google Scholar]
  • 13.Mark HH, Robbins KP, Mark TL. Axial length in applanation tonometry. J Cataract Refract Surg. 2002;28(3):504–6. Epub 2002/04/26. 10.1016/s0886-3350(01)01091-4 . [DOI] [PubMed] [Google Scholar]
  • 14.Altan C, Kara N, Baz O, Satana B, Demirok A, Yilmaz OF. Corneal biomechanical properties and intraocular pressure measurement in patients with nanophthalmos. Br J Ophthalmol. 2012;96(6):806–10. Epub 2012/03/09. 10.1136/bjophthalmol-2011-300557 . [DOI] [PubMed] [Google Scholar]
  • 15.Mark HH. Corneal curvature in applanation tonometry. Am J Ophthalmol. 1973;76(2):223–4. Epub 1973/08/01. 10.1016/0002-9394(73)90164-5 . [DOI] [PubMed] [Google Scholar]
  • 16.Luce DA. Determining in vivo biomechanical properties of the cornea with an ocular response analyzer. J Cataract Refract Surg. 2005;31(1):156–62. Epub 2005/02/22. 10.1016/j.jcrs.2004.10.044 . [DOI] [PubMed] [Google Scholar]
  • 17.Vinciguerra R, Elsheikh A, Roberts CJ, Ambrosio R Jr., Kang DS, Lopes BT, et al. Influence of Pachymetry and Intraocular Pressure on Dynamic Corneal Response Parameters in Healthy Patients. J Refract Surg (Thorofare, NJ: 1995). 2016;32(8):550–61. Epub 2016/08/10. 10.3928/1081597x-20160524-01 . [DOI] [PubMed] [Google Scholar]
  • 18.Matsuura M, Murata H, Fujino Y, Yanagisawa M, Nakao Y, Nakakura S, et al. Repeatability of the Novel Intraocular Pressure Measurement From Corvis ST. Transl Vis Sci Technol. 2019;8(3):48 Epub 2019/07/06. 10.1167/tvst.8.3.48 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Perez-Rico C, Gutierrez-Ortiz C, Gonzalez-Mesa A, Zandueta AM, Moreno-Salgueiro A, Germain F. Effect of diabetes mellitus on Corvis ST measurement process. Acta Ophthalmol. 2015;93(3):e193–e8. 10.1111/aos.12530 WOS:000353053000003. [DOI] [PubMed] [Google Scholar]
  • 20.Wang C, Li AL, Pang Y, Lei YQ, Yu L. Changes in intraocular pressure and central corneal thickness during pregnancy: a systematic review and Meta-analysis. Int J Ophthalmol. 2017;10(10):1573–9. Epub 2017/10/25. 10.18240/ijo.2017.10.15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Reznicek L, Muth D, Kampik A, Neubauer AS, Hirneiss C. Evaluation of a novel Scheimpflug-based non-contact tonometer in healthy subjects and patients with ocular hypertension and glaucoma. Br J Ophthalmol. 2013;97(11):1410–4. 10.1136/bjophthalmol-2013-303400 . [DOI] [PubMed] [Google Scholar]
  • 22.Vinciguerra R, Rehman S, Vallabh NA, Batterbury M, Czanner G, Choudhary A, et al. Corneal biomechanics and biomechanically corrected intraocular pressure in primary open-angle glaucoma, ocular hypertension and controls. Br J Ophthalmol. 2020;104(1):121–6. Epub 2019/03/30. 10.1136/bjophthalmol-2018-313493 . [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hong J, Xu J, Wei A, Deng SX, Cui X, Yu X, et al. A new tonometer—the Corvis ST tonometer: clinical comparison with noncontact and Goldmann applanation tonometers. Invest Ophthalmol Vis Sci. 2013;54(1):659–65. Epub 2013/01/12. 10.1167/iovs.12-10984 . [DOI] [PubMed] [Google Scholar]
  • 24.Smedowski A, Weglarz B, Tarnawska D, Kaarniranta K, Wylegala E. Comparison of three intraocular pressure measurement methods including biomechanical properties of the cornea. Invest Ophthalmol Vis Sci. 2014;55(2):666–73. Epub 2014/01/16. 10.1167/iovs.13-13172 . [DOI] [PubMed] [Google Scholar]
  • 25.Lanza M, Iaccarino S, Cennamo M, Irregolare C, Romano V, Carnevale UA. Comparison between Corvis and other tonometers in healthy eyes. Cont Lens Anterior Eye. 2015;38(2):94–8. Epub 2014/12/04. 10.1016/j.clae.2014.11.001 . [DOI] [PubMed] [Google Scholar]
  • 26.Jorge J, Diaz-Rey JA, Gonzalez-Meijome JM, Almeida JB, Parafita MA. Clinical performance of the Reichert AT550: a new non-contact tonometer. Ophthalmic Physiol Opt. 2002;22(6):560–4. Epub 2002/12/13. 10.1046/j.1475-1313.2002.00077.x . [DOI] [PubMed] [Google Scholar]
  • 27.Jorge J, Gonzalez-Meijome JM, Diaz-Rey JA, Almeida JB, Ribeiro P, Parafita MA. Clinical performance of non-contact tonometry by Reichert AT550 in glaucomatous patients. Ophthalmic Physiol Opt. 2003;23(6):503–6. Epub 2003/11/19. 10.1046/j.1475-1313.2003.00139.x . [DOI] [PubMed] [Google Scholar]
  • 28.Schiano Lomoriello D, Lombardo M, Tranchina L, Oddone F, Serrao S, Ducoli P. Repeatability of intra-ocular pressure and central corneal thickness measurements provided by a non-contact method of tonometry and pachymetry. Graefes Arch Clin Exp Ophthalmol. 2011;249(3):429–34. Epub 2010/10/29. 10.1007/s00417-010-1550-3 . [DOI] [PubMed] [Google Scholar]
  • 29.Niesel P, Flammer J. Correlations between intraocular pressure, visual field and visual acuity, based on 11 years of observations of treated chronic glaucomas. Int J Ophthalmol. 1980;3(1):31–5. Epub 1980/12/01. 10.1007/bf00136211 . [DOI] [PubMed] [Google Scholar]
  • 30.Seidman C, De Moraes CG, Je RF, Liebmann R, Ritch R. The Relationship Between Visual Acuity, Intraocular Pressure, and Rates of Visual Field Progression Using 10–2 Perimetry. Invest Ophthalmol Vis Sci. 2013;54(15). WOS:000436232709029. [Google Scholar]
  • 31.Azuara-Blanco A, Katz LJ, Spaeth GL, Wilson RP, Moster MR, Flartey KJ. Effect of latanoprost on intraocular pressure in patients with glaucoma on maximal tolerated medical treatment. Br J Ophthalmol. 1997;81(12):1116 Epub 1998/03/14. 10.1136/bjo.81.12.1115b [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Lee DA, Gornbein JA. Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial. J Glaucoma. 2001;10(3):220–6. Epub 2001/07/10. 10.1097/00061198-200106000-00014 . [DOI] [PubMed] [Google Scholar]

Decision Letter 0

Rajiv R Mohan

5 May 2020

PONE-D-20-07468

Evaluation of biomechanically corrected intraocular pressure using Corvis ST and comparison of the Corvis ST, noncontact tonometer, and Goldmann applanation tonometer in patients with glaucoma

PLOS ONE

Dear %Dr% %Nakao%,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

We would appreciate receiving your revised manuscript by Jun 19 2020 11:59PM. When you are ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter.

To enhance the reproducibility of your results, we recommend that if applicable you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). This letter should be uploaded as separate file and labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. This file should be uploaded as separate file and labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. This file should be uploaded as separate file and labeled 'Manuscript'.

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

We look forward to receiving your revised manuscript.

Kind regards,

Rajiv R. Mohan, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (if provided):

Dear authors,

I wish to inform that your MSS has been reviewed by the two reviewers and EBM, and requires addressing of some key points/issues. It is recommended to read the concerns and address them appropriately for the consideration of publication.

Thank you

Rajiv Mohan

Journal requirements:

When submitting your revision, we need you to address these additional requirements:

1.    Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at http://www.plosone.org/attachments/PLOSOne_formatting_sample_main_body.pdf and http://www.plosone.org/attachments/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This is an interesting and current article but needs adjustments such as improving the explanation in the introduction on the thickness and biomechanics of the cornea, citing the competing device (ORA) that was the first to use this type of technology and giving more details on how Corvis works ST.

In the methodology, you should mention inclusion criteria (minimum visual acuity, how many drugs the patient is using, minimum and maximum IOP included in the work), think about including pregnant women and ocular hypertensive patients in the exclusion criteria and better explain the power of the sample.

It uses adequate statistics and correlates well the data of the proposed methodology.

In the discussion, he concludes about the proposed methodology and results and reports the negative points. Among them, there is a fundamental issue that would be the inclusion of a control group to correlate and compare data from patients with glaucoma.

Reviewer #2: The paper is written to investigate the IOP measured by Corvis, NCT and GAT. However, there are still some questions existed and need to be checked.

Major comments

1. The IOP values in glaucoma is not exactly same to normal eyes, it should add the comparsion of the IOP measured by Corvis, NCT and GAT in normal eyes.

2. The author found the IOP-GAT measurements had the highest values (13.5 ± 2.1 mmHg [mean ± SD]), followed by IOP-NCT (13.2 ± 2.7 mmHg), IOP-Corvis (10.6 ± 2.8 mmHg), and bIOP-Corvis (10.0 ± 2.3 mmHg). The statistically analysis (such as analysis of variance, and SNK method) is needed to compare the IOP values.

3. In Table 2, the author used the univariate and multivariate regression analyses. There are no significantly differences of bIOP-Corvis and IOP-GAT in the univariate results, which should not further conduct multivariate regression analyses, please checks it.

4. The clinical application of four IOP values needs to be discussed and the discussion should more deeply.

Minor comments.

1. Page 14 line 12, check the sentence “This showed that that the……”

2. the Corvis ST only occurred in title, which is not mentioned in main documents.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files to be viewed.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2020 Sep 23;15(9):e0238395. doi: 10.1371/journal.pone.0238395.r002

Author response to Decision Letter 0


27 May 2020

Dear Dr Rajiv R. Mohan, we would like to thank you and the reviewers for their constructive and insightful reviews. We believe that the points raised, and our revisions, have resulted in an improved manuscript again. Our responses to the suggested revisions follow.

Reviewer #1:

Thank you very much. Please find the comments and corrections added in the manuscript.

This is an interesting and current article but needs adjustments such as improving the explanation in the introduction on the thickness and biomechanics of the cornea, citing the competing device (ORA) that was the first to use this type of technology and giving more details on how Corvis works ST.

Thank you very much for this comment. We agree with you. We added the sentence below in the introduction section (Page 4 Line 52).

“Nevertheless, IOP readings increased as the CCT increased [2-12], axial length decreased [13, 14], age increased [9, 12], and the corneal curvature decreased [8, 15] when the two tonometers are used.

In 2005, to provide a corrected IOP unaffected by CCT, the Ocular Response Analyzer (ORA; Reichert, Delpew, NY, USA) was introduced [16]. The ORA was the first non-contact tonometer to convert corneal biomechanics into numerical values using dynamic infrared signal analysis of the corneal biomechanical response. However, the ORA cannot provide a direct description of the mechanical behavior of the cornea.

More recently, the Corneal Visualization Scheimpflug Technology (Corvis ST; Oculus, Wetzlar, Germany) has been introduced as a novel non-contact tonometer designed to accurately measure IOP and the detailed biomechanical response of the cornea to an air pulse. The Corvis ST records the corneal reaction to a defined air pulse with a Scheimpflug imaging system that takes about 4,330 images per second. Then, it estimates the corrected IOP without the influence of ocular biomechanical parameters, including CCT or aging; it is named as IOPpachy-Corvis.”

In the methodology, you should mention inclusion criteria (minimum visual acuity, how many drugs the patient is using, minimum and maximum IOP included in the work), think about including pregnant women and ocular hypertensive patients in the exclusion criteria and better explain the power of the sample.

Thank you very much. We totally agree with you. We did not consider the inclusion criteria about minimum visual acuity, how many drugs the patient is using, minimum and maximum IOP in advance. As discussed above, we added the limitations in the discussion section (Page 18 Line 266).

“Second, our participants included only patients with POAG. It is unclear whether our results can be applicable to healthy patients and those without POAG. Third, our participants were treated using antiglaucoma medications, which are intended to reduce elevated intraocular pressure. Thus, the IOPs measured in our participants all seemed within the normal range. Our results may not generalize to those with higher IOP measurements. Fourth, our study did not consider other factors that may influence IOP readings, such as visual acuity [29, 30] and number of antiglaucoma medications [31, 32], and future research is desired in this aspect.”

And we added the visual acuity data (mean±standard deviation and range) in the table1 (Page 9 Line 142)

Table 1. Demographics and ocular characteristics of patients (POAG, n=71)

We include a pregnant women and ocular hypertensive patients in the exclusion criteria in the Materials and Methods section (Page7 Line107).

“The exclusion criteria included intraocular surgery or refractive laser treatment and any systemic or ocular pathology that could affect the IOP measurements; refractive error equal to or exceeding -6.00 diopter equivalent sphere, and corneal astigmatism equal to or exceeding 3.00 diopters; ocular hypertension; diabetes [19]; pregnancy [20]; and Scheimpflug images with a low quality, which cannot be automatically analyzed.”

And we tried to explain the power of the sample in the statistical analysis section (Page 8 Line 122/ Page 9 Line 132).

“IOP measurements were compared using a repeated measures ANOVA and a paired t-test with Bonferroni correction. A sample size of 50 participants was needed to achieve 80% power to detect a minimal clinically important difference of 1.5 mmHg, assuming a standard deviation of 1.75 mmHg in the differences between IOPs, a significance level of 0.05, and a 10% patient ineligibility.”

“The target sample size estimates were based on the effect size f2 (0.15); number of predictors (4); significance level (0.05); and power (80%). Considering 10% of patients to be ineligible, the target sample size was determined to be at least 61 patients. "

It uses adequate statistics and correlates well the data of the proposed methodology.

In the discussion, he concludes about the proposed methodology and results and reports the negative points. Among them, there is a fundamental issue that would be the inclusion of a control group to correlate and compare data from patients with glaucoma.

Thank you so much. We totally agree with you. In the future, we need to compare between healthy subjects and patients with glaucoma. We added the sentence below to the limitation in the discussion section (Page 18 Line 266).

“Second, our participants included only patients with POAG. It is unclear whether our results can be applicable to healthy patients and those without POAG.”

Reviewer #2: The paper is written to investigate the IOP measured by Corvis, NCT and GAT. However, there are still some questions existed and need to be checked.

Thank you so much. Please find the comments and corrections added in the manuscript.

Major comments

1. The IOP values in glaucoma is not exactly same to normal eyes, it should add the comparsion of the IOP measured by Corvis, NCT and GAT in normal eyes.

Thank you very much. We totally agree with you and Reviewer1. In the future, we need to compare between healthy subjects and patients with glaucoma. We added the sentence below to the limitation in the discussion section (Page 18 Line 266).

“Second, our participants included only patients with POAG. It is unclear whether our results can be applicable to healthy patients and those without POAG.”

2. The author found the IOP-GAT measurements had the highest values (13.5 ± 2.1 mmHg [mean ± SD]), followed by IOP-NCT (13.2 ± 2.7 mmHg), IOP-Corvis (10.6 ± 2.8 mmHg), and bIOP-Corvis (10.0 ± 2.3 mmHg). The statistically analysis (such as analysis of variance, and SNK method) is needed to compare the IOP values.

Thank you very much. We agree with your opinion. As discussed above, we decided to utilize a repeated measures ANOVA and a paired t-test with Bonferroni correction.

We added the sentence below in the abstract section (Page 2 Line 26)

“We included 71 patients with primary open-angle glaucoma and assessed their IOP measurements obtained with the GAT, NCT, and Corvis ST using a repeated measures ANOVA, a paired t-test with Bonferroni correction, stepwise multiple regression analyses and Bland–Altman plots.”

And in the statistical analysis section (Page 8 Line 122)

“IOP measurements were compared using a repeated measures ANOVA and a paired t-test with Bonferroni correction.”

And in the results section (Page 10 Line 155).

“We found a significant difference between the IOP measurements by using a repeated measures ANOVA (all, p <0.001). In the paired t-test with Bonferroni correction, bIOP-Corvis obtained significantly the lowest values of the four IOP measurements (all, p <0.001). IOP-Corvis produced significantly lower values than IOP-NCT and IOP-GAT (all, p <0.001); however, we found no significant differences between IOP-NCT and IOP-GAT (p >0.05).”

3. In Table 2, the author used the univariate and multivariate regression analyses. There are no significantly differences of bIOP-Corvis and IOP-GAT in the univariate results, which should not further conduct multivariate regression analyses, please checks it.

Thank you so much. We agree with you. We do not need to further conduct multivariate regression analyses for bIOP-Corvis and IOP-GAT. We corrected the table 2 (Page 12)

4. The clinical application of four IOP values needs to be discussed and the discussion should more deeply.

Thank you very much. As discussed above, we added the sentence below in the discussion section (Page 17 Line 251).

“Advantages and disadvantages of bIOP-Corvis

Most commercially available tonometers estimate IOP based on the corneal applanation or indentation. Therefore, measured values of IOP are generally influenced by corneal biomechanics. The bIOP-Corvis is an estimate of the corrected IOP, which is minimally influenced by ocular biomechanical parameters. In this study, we used regression analyses to investigate the anatomical and structural factors that affect the bIOP-Corvis measurements. We found that age, average corneal curvature, axial length, and CCT were not significant factors that influence bIOP-Corvis. However, our result of the Bland–Altman plots for bIOP-Corvis and IOP-GAT showed that fixed biases were identified. This means that bIOP-Corvis significantly underestimated IOP using the standard clinical tonometer for measurements. Nevertheless, proportional bias was not between the bIOP-Corvis and IOP-GAT measurements and the 95% LOAs was relatively low. Therefore, it seems that we can convert from bIOP-Corvis to IOP-GAT. Our result implied that the bIOP-Corvis is a useful IOP value in patients with POAG.”

Minor comments.

1. Page 14 line 12, check the sentence “This showed that that the……”

Thank you so much. We corrected the sentence (Page 16 Line 236).

“This showed that the differences between two IOP values (bIOP-Corvis and IOP-GAT) neither increase nor decrease in proportion to the average values; therefore, it can be easily converted from bIOP-Corvis to IOP-GAT.”

2. the Corvis ST only occurred in title, which is not mentioned in main documents.

Thank you very much. We added the sentence below in the abstract section (Page 2 Line 19)

“The aim of the study was to investigate the effects of various anatomical structures on intraocular pressure (IOP) measurements obtained by the Corneal Visualization Scheimpflug Technology (Corvis ST)”

And in the introduction section (Page 5 Line 64).

“More recently, the Corneal Visualization Scheimpflug Technology (Corvis ST; Oculus, Wetzlar, Germany) has been introduced as a novel non-contact tonometer designed to accurately measure IOP and the detailed biomechanical response of the cornea to an air pulse. The Corvis ST records the corneal reaction to a defined air pulse with a Scheimpflug imaging system that takes about 4,330 images per second.”

And we added the words ”Corvis ST” below in Page 5 Line73/ Page6 Line 91/ Page 7 Line 112/ Page 8 Line 114, 117/ Page 10 Line 152/ Page 13 Line 179, 182/ Page 17 Line 249/ Page 18 Line 265/ Page 19 Line 285

Attachment

Submitted filename: Response to Reviewers.docx

Decision Letter 1

Rajiv R Mohan

17 Aug 2020

Evaluation of biomechanically corrected intraocular pressure using Corvis ST and comparison of the Corvis ST, noncontact tonometer, and Goldmann applanation tonometer in patients with glaucoma

PONE-D-20-07468R1

Dear Dr. Nakao,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Rajiv R. Mohan, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: No

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The previous question has been revised, and there are still some inaccuracies. The author added ocular hypertension, diabetes and pregnancy to the exclusion criteria, which changed the sample size. Although the results will not change significantly, the authors should perform statistical analysis based on the new sample after exclusion criteria.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

Acceptance letter

Rajiv R Mohan

14 Sep 2020

PONE-D-20-07468R1

Evaluation of biomechanically corrected intraocular pressure using Corvis ST and comparison of the Corvis ST, noncontact tonometer, and Goldmann applanation tonometer in patients with glaucoma

Dear Dr. Nakao:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Rajiv R. Mohan

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: Response to Reviewers.docx

    Data Availability Statement

    All our study datas are available from the figshare database (10.6084/m9.figshare.11954748).


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES